Proshares Ultra Health Etf Price To Book

RXL Etf  USD 48.44  0.79  1.66%   
ProShares Ultra Health fundamentals help investors to digest information that contributes to ProShares Ultra's financial success or failures. It also enables traders to predict the movement of ProShares Etf. The fundamental analysis module provides a way to measure ProShares Ultra's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProShares Ultra etf.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ProShares Ultra Health ETF Price To Book Analysis

ProShares Ultra's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current ProShares Ultra Price To Book

    
  2.99 X  
Most of ProShares Ultra's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProShares Ultra Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

ProShares Ultra Price To Book Component Assessment

Based on the latest financial disclosure, ProShares Ultra Health has a Price To Book of 2.99 times. This is 278.48% higher than that of the ProShares family and 10.12% lower than that of the Family category. The price to book for all United States etfs is notably lower than that of the firm.

ProShares Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ProShares Ultra's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of ProShares Ultra could also be used in its relative valuation, which is a method of valuing ProShares Ultra by comparing valuation metrics of similar companies.
ProShares Ultra is currently under evaluation in price to book as compared to similar ETFs.

Fund Asset Allocation for ProShares Ultra

The fund invests 200.06% of asset under management in tradable equity instruments, with the rest of investments concentrated in .
Asset allocation divides ProShares Ultra's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.

ProShares Fundamentals

About ProShares Ultra Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ProShares Ultra Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProShares Ultra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProShares Ultra Health based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ProShares Ultra Health is a strong investment it is important to analyze ProShares Ultra's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProShares Ultra's future performance. For an informed investment choice regarding ProShares Etf, refer to the following important reports:
Check out ProShares Ultra Piotroski F Score and ProShares Ultra Altman Z Score analysis.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
The market value of ProShares Ultra Health is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Ultra's value that differs from its market value or its book value, called intrinsic value, which is ProShares Ultra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Ultra's market value can be influenced by many factors that don't directly affect ProShares Ultra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Ultra's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Ultra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Ultra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.